This article comes to us from FiercePharma. As the landscape for Big Pharma continues to change - new strategies are being developed with the focus in three distinct areas: Brand Generics, emerging markets and personalized medicine. Inherent in these strategies are the proper tools for clinical data management - and how companies leverage them to get the most out of their initiatives.